- Home
- GNTA
as 11-21-2024 4:00pm EST
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.
| Founded: | 2014 | Country: | Italy |
| Employees: | N/A | City: | N/A |
| Market Cap: | 96.9M | IPO Year: | 2021 |
| Target Price: | $25.00 | AVG Volume (30 days): | 7.4K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.52 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.20 - $7.28 | Next Earning Date: | 01-01-0001 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Genenta Science S.p.A. News
GNTA Breaking Stock News: Dive into GNTA Ticker-Specific Updates for Smart Investing
Simply Wall St.
8 days ago
3 US Penny Stocks With Market Caps Over $30M To Consider
GlobeNewswire
a month ago
Genenta’s CEO to present at the U.S. Senate meeting on “Cross-Border Investments and Strategies in the Biotechnology Sector: A Transatlantic Perspective”
Simply Wall St.
a month ago
Genenta Science S.p.A.'s (NASDAQ:GNTA) market cap rose US$46m last week; individual investors who hold 55% profited and so did insiders
MT Newswires
2 months ago
Genenta Science Receives Regulatory Approval in Italy for Phase 1 Temferon Trial
GlobeNewswire
2 months ago
Genenta Secures Approval for Innovative Trial for Metastatic Renal Cell Cancer
Insider Monkey
2 months ago
Genenta Science S.p.A. (GNTA): Early Investment Opportunity in Innovative Biotech
GOBankingRates
5 months ago
3 Types of Homes To Buy During Summer 2024 To Get Rich
GOBankingRates
5 months ago
4 Ways the Upper Class Handles Inflation That the Middle Class Could Learn From
Compare GNTA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "GNTA Genenta Science S.p.A. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.